Sunday, June 29, 2008
Real news in Real Time! National and international updates on all products by leading agencies such as Dow Jones, Capital Markets, Commodities Control and more.


Capital Market Live News
Jun 21 2008 1:59PM
Mavens Biotech recommends dividend
The board of Mavens Biotech has recommended dividend at the rate of Rs 0.30 per share for the year ended 31 March 2008.

Tha board has decided to subdivide 1 existing equity share of face value of Rs 10 each into 10 equity shares of face value of Re 1 each with effect from the record date to be determined.

The board has decided to hold EGM on 17 July 2008.

These were decided at the board meeting held on 20 June 2008.

Powered byCapital Market - Live News

  Source:   

   Capital Market Disclaimer
Back
 
 
News
 
Research
 
Markets
 
Knowledge Center
 
Technical Charts
 
Customer Service
 
Branch Locator
 
Careers
 






SEBI | BSE | NSE
Terms & Conditions | Disclaimer | Online Privacy | Trouble Logging in | Glossary | Site Map
Copyright© 2008. All rights Reserved. Reliance Money Limited
Equities: Trading through Reliance Securities Limited | NSE SEBI Registration Number Capital Market :- INB 231234833 | BSE SEBI
Registration Number Capital Market :- INB 011234839 | NSE SEBI Registration Number Derivatives :- INF 231234833 Commodities : Trading through Reliance Commodities Limited | MCX member code: 29030 | NCDEX member code: NCDEX-CO-05-00647|
NMCE member code: CL0120 Mutual Funds : Reliance Securities Limited | AMFI ARN No.29889
In case of any grievances please write to [email protected]